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In today’s postgenomic era, protein modules are an-
notated and grouped into families based on their se-
quence conservation, allowing for the prediction of
function and binding partners based on perceived evo-
lutionary relationships. Although sequence compari-
sons are a rich source of information, exceptions to
functional conservation can be hidden at the sequence
level, as exemplified by the present example of phos-
photyrosine recognition by the C2 domain. Amusingly,
structural comparisons showed that an E. coli protein
known as BirA contains an SH2 domain and that the
SH2 domain of BirA binds biotin at the same site that
is used for phosphotyrosine binding in SH2 domains
(Russell and Barton, 1993). It might well be that the ven-
erable old SH2 domain still has a few tricks up its
sleeve, such as recognizing phosphothreonine or phos-
phoserine, as one study has suggested (Pendergast et
al., 1991). Watch this space.
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In this issue of Cell, a study by Adolfsson and co- o
workers (Adolfsson et al., 2005) provides insight into u
the early lineage commitment events of multipotent r
hematopoietic stem cells (HSCs). These studies de- t
omonstrate the importance of the Flt3 receptor tyro-sine kinase as the earliest marker of hematopoietic
cell fate commitment in that erythrocyte and mega-
karyocyte potentials are lost first as HSCs differenti-
ate to lymphocyte progenitors.
Understanding how multipotent cells commit to each
of their terminal fate potentials is an important aspect
of stem cell biology. Within the hematopoietic system,
the prospective isolation of stem and progenitor cell
subsets by cell surface phenotype has identified the
branch points at which major lineage decisions occur.
This approach has been instrumental in creating the
fate maps necessary to understand the hierarchical
loss of lineage potential as multipotent hematopoietic
stem cells (HSCs) differentiate (Traver and Akashi,
2004). HSCs with long-term (LT) self-renewal potential
have been purified from within the cell population
known as Lin−Sca-1+c-Kit+ (LSK) by using additional
cell surface markers such as Thy1.1 expression or lack
of Flt3 and CD34 expression (Figure 1A) (Adolfsson et
al., 2001; Osawa et al., 1996). Importantly, these cells
can reconstitute multilineage hematopoiesis for more
than six months following single cell transplantation. In
contrast, Flt3+ or CD34+ LSK cells do not appreciably
self renew, being capable of multilineage reconstitution
for only short-term (ST) periods of time. Upon loss of
Sca-1 expression by ST-HSCs, myeloid-committed pro-
genitor cells, including common myeloid progenitors
(CMPs), granulocyte/monocyte progenitors (GMPs), and
megakaryocyte/erythrocyte progenitors (MEPs), have
been purified by cell surface phenotype (Figure 1A)
(Akashi et al., 2000). Similarly, common lymphoid pro-
genitors (CLPs) have been isolated from the IL-
7Ra+Sca-1loc-Kitlo fraction (Kondo et al., 1997). Based
on the existence of these defined progenitor popula-
tions, the first lineage commitment steps had been
considered to occur downstream of ST-HSCs, with the
myeloid and lymphoid developmental pathways being
largely independent (Figure 1A).
Recently, several studies have suggested that lineage
commitment may occur at the level of ST-HSCs and
precede a simple bifurcation of myeloid and lymphoid
fates. Spangrude et al. have reported that Thy-1− ST
LSK cells failed to reconstitute the erythroid lineage ef-
ficiently, and that this population gradually lost ery-
throid potential in vitro (Slayton et al., 2001). Igarashi et
al. reported that ST-HSCs contain a fraction of cells that
express rag-1, a lymphoid-specific gene, and that
these RAG-1+ LSK cells, termed early lymphoid progen-
itors (ELPs), differentiated mainly into lymphoid lin-
ages but retained weak granulocyte/monocyte (G/M)
otential (Igarashi et al., 2002). Thus, the loss of G/M
otential could be the final event in lymphoid commit-
ent as ST-HSCs transit to lymphoid-restricted pro-
enitors.
Adolfsson et al. (2005) have now identified a Flt3+
opulation within the ST LSK fraction that features ro-
ust lymphoid potential and the ability to generate
/M lineages. Whereas previous studies by this (Ad-
lfsson et al., 2001) group have demonstrated that
pregulation of Flt3 by LT-HSCs marks loss of self-
enewal potential, this new work is the first demonstra-
ion that this loss is coupled functionally with a loss
f erythrocyte/megakaryocyte (E/Meg) potential. LSK
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161Figure 1. Fate Map of Hematopoietic Stem Cell Commitment Based on the Differential Expression of the Sca-1 and c-Kit Cell Surface Re-
ceptors
In the conventional model (A), the loss of myeloerythroid potential occurs abruptly when LSK cells produce CLPs, whereas a new model (B)
predicts that LSK cells sequentially lose Meg/E and then G/M potential during lymphoid commitment.CD34+Flt-3+ cells gave rise to G/M, T, and B cells in
vitro but rarely formed megakaryocyte or erythroid col-
onies. After transplantation, the contribution of LSK
CD34+Flt-3+ cells to erythroid development was weak
when compared to their Flt-3− counterparts. Thus, they
propose that Flt3 expression within ST-HSCs marks a
new committed progenitor that is able to both generate
lymphoid progeny and bypass the CMP stage in gener-
ating G/M progeny.
The most interesting finding of this study is that
E/Meg potential is lost first as HSCs commit to differen-
tiation. Rather than a mutually exclusive bifurcation of
myeloid and lymphoid potential, as previously pro-
posed (Akashi et al., 2000), this work demonstrates that
the E/Meg differentiation program can be shut down
before G/M potential is lost. A major question remaining
is whether these findings represent a common physio-
logical differentiation pathway for both myeloid and
lymphoid lineages or whether these findings simply re-
flect an ordered loss of myeloid potentials as ST-HSCs
commit to lymphoid fates via the CLP. Importantly, lin-
eage relationship experiments were previously per-
formed that demonstrated the CLP is a direct descen-
dant of Flt3+ LSK cells (Adolfsson et al., 2001). If this
new progenitor subset represents a new G/M pathway
as proposed, it would be expected that GMPs would
also be downstream of this cell type. This experiment
remains to be performed, as do studies aimed at deter-
mining the relative contribution of this fraction to nor-
mal, steady-state G/M production. Molecular analyses
demonstrated that only 7% of Flt3+ LSK cells coex-
pressed lymphoid and myeloid genes, suggesting that
the noted bipotentiality may reflect heterogeneity within
this fraction. This expression profile is in contrast to
other bipotent populations such as the CMP, wheremore than 60% of single cells coexpressed G/M and
E/Meg genes. Further work is thus required to ascertain
the role of Flt3+ LSK cells in normal myeloid cell devel-
opment.
Previous reports have shown that, while Flt3 ligand
is dispensable for G/M development, it is critical for the
generation of CLPs from Flt3+ LSK cells (Sitnicka et al.,
2002). Recent studies have also suggested that the
CMP population can be subdivided by Flt3 expression.
Interestingly, the minor B lymphoid potential described
within this fraction, as well as most of the dendritic cell
potential, was contained within the Flt3+ subset (D’Am-
ico and Wu, 2003). Together, these results further sup-
port an important role of Flt3 signaling in lymphoid
commitment and warrant more precise studies examin-
ing the lineage relationships of these new progenitor
cell subsets with those previously identified. In addition
to improved lineage studies, an issue that many recent
studies have raised is a failure to compare populations
that are identical to those published by other groups.
For example, both Adolfsson et al. (2005) and D’Amico
and Wu (2003) claim to subdivide the CMP population
by Flt3 expression. Both groups however, due to appar-
ent technical limitations, substituted visualization of
Flt3 for an important CMP marker. Failure to study Flt3
expression in the context of the conventional myeloid
progenitor isolation protocol results in contamination of
the CMP subset with other cell types, yet isolated frac-
tions were termed Flt3+ or Flt3− “CMPs.” This has be-
come a common problem in the stem and progenitor
cell field and is not acceptable if one truly wishes to
compare identical populations. Improvements in flow
cytometry, such as the inclusion of additional antibod-
ies coupled to additional fluorochromes, need to be
achieved by the field to enable meaningful compari-
sons between laboratories.
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ferences in cell surface markers that correlate with cell
fate commitments. These commitment events are gen-
erally associated with changes in transcriptional regu-
lation. Continued examination of current and yet-to-be-
discovered stem and progenitor cell subsets will be
important in determining the molecular mechanisms
underlying hematopoietic fate commitment and in cre-
ating high-resolution maps for all blood cell lineages.
Koichi Akashi,1 David Traver,2 and Leonard I. Zon3
1Department of Cancer Immunology and AIDS
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts 02115
2Section of Cell and Developmental Biology
University of California, San Diego
San Diego, California 92093
3Children’s Hospital
Howard Hughes Medical Institute and
Harvard University Medical School
Boston, Massachusetts 02115
Selected Reading
Adolfsson, J., Borge, O.J., Bryder, D., Theilgaard-Monch, K.,
Astrand-Grundstrom, I., Sitnicka, E., Sasaki, Y., and Jacobsen, S.E.
(2001). Immunity 15, 659–669.
Adolfsson, J., Mansson, R., Buza-Vidas, N., Hultquist, A., Liuba, K.,
Jensen, C.T., Bryder, D., Yang, L., Borge, O.-J., Thoren, L., et al.
(2005). Cell 121, this issue, 295–306.
Akashi, K., Traver, D., Miyamoto, T., and Weissman, I.L. (2000). Na-
ture 404, 193–197.
D’Amico, A.D., and Wu, L. (2003). J. Exp. Med. 198, 293–303.
Igarashi, H., Gregory, S.C., Yokota, T., Sakaguchi, N., and Kincade,
P.W. (2002). Immunity 17, 117–130.
Kondo, M., Weissman, I.L., and Akashi, K. (1997). Cell 91, 661–672.
Osawa, M., Hanada, K., Hamada, H., and Nakauchi, H. (1996). Sci-
ence 273, 242–245.
Sitnicka, E., Bryder, D., Theilgaard-Monch, K., Buza-Vidas, N., Ad-
olfsson, J., and Jacobsen, S.E. (2002). Immunity 17, 463–472.
Slayton, W.B., Mojica, M.P., Pierce, L.J., and Spangrude, G.J.
(2001). Ann. N Y Acad. Sci. 938, 157–165.
Traver, D., and Akashi, K. (2004). Adv. Immunol. 83, 1–54.
DOI 10.1016/j.cell.2005.04.005
